Physical Activity Program and Nutrition Therapeutic Education During Treatment of Head and Neck Cancer Population
NCT ID: NCT01910753
Last Updated: 2016-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
10 participants
INTERVENTIONAL
2013-05-31
2015-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Influencing Factors for Physical Activity in People With Head and Neck Cancer
NCT06272513
Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy
NCT02485470
Progressive Resistance Training Program in Head and Neck Cancer Patients
NCT02068950
Concurrent Training and Nutritional Management in Cancer
NCT03720015
Exercise and Nutrition for Head and Neck Cancer Patients
NCT01681654
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
APA
Patient with neck cancer and accepting the physical activity program .
APA
A 3-month program for physical activity and diet education will be followed. An exercise specialist will supervise patients twice per week, during the first six weeks. They will also follow nutrition counselling and therapeutic education by a dietician once per week. During the last six weeks, they will just follow a guide for safe and appropriate exercise regimen. The dietician will call patient weekly during this final period.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
APA
A 3-month program for physical activity and diet education will be followed. An exercise specialist will supervise patients twice per week, during the first six weeks. They will also follow nutrition counselling and therapeutic education by a dietician once per week. During the last six weeks, they will just follow a guide for safe and appropriate exercise regimen. The dietician will call patient weekly during this final period.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Written informed consent provided before any study specific procedures
* Consent to cooperate for clinical assessments
* Affiliation to a social security regime or beneficiary of equivalent social protection
* Performance status between 0 and 2
* Squamous cell carcinoma of oral cavity, oropharynx or hypopharynx
* Stage III - IV (T1-T4, N0-N3, M)(UICC 2002)
* Indication of radiotherapy and chemotherapy post-operative or first-line metastatic chemotherapy or in inoperable condition
* Ability to understand the nature, goal and study methodology
Exclusion Criteria
* timed vital capacity\< 70%
* Presence of another severe pathology including:
* severe or chronic cardiac, pulmonary, renal and/or hepatic insufficiencies
* Cons-indication to physical activity practice, at discretion of the investigator
* Patient under guardianship
* Psychological, social, geographical, or familial reasons prohibiting physical activity and follow-up
* Any other primary tumor during the last 5 years
* Pregnant or nursing
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Limoges
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
FRANCOIS Vincent, MD
Role: PRINCIPAL_INVESTIGATOR
Limoges UH
Sabrina FALKOWSKI, MD
Role: PRINCIPAL_INVESTIGATOR
CHU LIMOGES - Oncologie
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU LIMOGES - Explorations Fonctionnelles Respiratoires
Limoges, Limoges, France
CHU LIMOGES - Oncologie
Limoges, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
I12018 APANVADS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.